Certolizumab (Anti-TNFSF2 / TNFa)
Certolizumab (Anti-TNFSF2 / TNFa) (A2798-GRP)
Products
Description
Certolizumab (anti-TNFSF2 / TNFa) is a Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with anti-inflammatory activity. MW: 144.92 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2798 |
| Target | TNF-alpha |